Parathyroid hormone is associated with the LV mass after aortic valve replacement
Marie-Hélène Laflamme(Valve (United States)), Patrick Mathieu(Institut universitaire de cardiologie et de pneumologie de Québec), Marie‐Chloé Boulanger(Institut universitaire de cardiologie et de pneumologie de Québec), Philippe Pîbarot(Emory University), Éric Larose, Ablajan Mahmut(Valve (United States)), Haïfa Mahjoub(Institut universitaire de cardiologie et de pneumologie de Québec)
Cited by 9
Related Papers
Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients
|New England Journal of Medicine|2016|5.1k
Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients
|New England Journal of Medicine|2019|4.8k
Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis
|The Lancet|2016|1k
Five-Year Outcomes of Transcatheter or Surgical Aortic-Valve Replacement
|New England Journal of Medicine|2020|832
Staging classification of aortic stenosis based on the extent of cardiac damage
|European Heart Journal|2017|725